Invention Grant
- Patent Title: Self assembling molecules for targeted drug delivery
-
Application No.: US16694437Application Date: 2019-11-25
-
Publication No.: US11666664B2Publication Date: 2023-06-06
- Inventor: David R. Elmaleh , Kazue Takahashi
- Applicant: The General Hospital Corporation
- Applicant Address: US MA Boston
- Assignee: The General Hospital Corporation
- Current Assignee: The General Hospital Corporation
- Current Assignee Address: US MA Boston
- Agency: Foley Hoag LLP
- Agent Janine S. Ladislaw; Allison L. Gilder
- Main IPC: A61K39/00
- IPC: A61K39/00 ; C07K16/00 ; A61K47/69 ; A61K9/51 ; A61K47/62 ; A61K47/68 ; A61P35/00 ; A61K9/50 ; A61K31/337 ; A61K31/473 ; A61K31/7068 ; A61K39/39 ; A61K49/00 ; A61K49/18 ; A61K51/12
Abstract:
Described herein are self-assembling protein molecules for delivering a payload, for example, a toxic anti-cancer agent, a cancer immunotherapy, a toxic anti-cancer agent and a cancer immunotherapy, or an imaging agent, to specific tissues. Examples of self-assembled proteins include clathrin and derivatives of clathrin.
Public/Granted literature
- US20200078472A1 SELF ASSEMBLING MOLECULES FOR TARGETED DRUG DELIVERY Public/Granted day:2020-03-12
Information query
